CSI Market
Sign In | Register

Intra cellular Therapies Inc (ITCI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ITCI Annual Cash Flow →
The data below summarizes Intra cellular Therapies Inc's cash flow activity from Dec 31 2023 to Dec 31 2024, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-74.68
Depreciation & amortization0.51
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-14.91
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation64.12
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Accrued Customer Programs17.36
Increase Decrease In Operating Lease Liability-0.31
Income taxes0.00
Unrealized Gain (Loss) on Investments0.00
Accounts Receivable-45.07
Increase (Decrease) in Accounts Payable14.62
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities37.27
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-67.79
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-9.03
Discontinued operations0.00
Net Cash flow from Operating Activities-73.18
Investing Activities
Capital Expenditures-0.32
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments-334.83
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-335.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock567.51
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Common Stock Subscribed-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities567.51
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-73.50
Total Cash Flow159.18
4 historic quarters locked

Sign in to unlock the full Intra cellular Therapies Inc cash flow history.

Sign In Create Free Account

About Intra cellular Therapies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-044196

Figures are derived from filed reports and may be restated. Historical data is subject to revision.